乐鱼在线

Providing innovative and affordable medicines
for all patients
Henlius has built an integrated and efficient global R&D platform to ensure the highly productive and cost-efficient R&D processes. The global innovation centre is responsible for research and early development from cell line construction and screening to upstream/downstream process development, formulation development and analytical process development with continuous exploration in cutting-edge production technologies. It has established a new payload-linker and conjugate technology platform with proprietary IP rights and a bispecific antibody engineering platform including synthetic humanised llama VHH library (2x1012), VHH- and scFv-based bispecific screening and engineering and linker design.
var _hmt = _hmt || []; (function() { var hm = document.createElement("script"); hm.src = "https://hm.baidu.com/hm.js?90c4d9819bca8c9bf01e7898dd269864"; var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s); })(); !function(p){"use strict";!function(t){var s=window,e=document,i=p,c="".concat("https:"===e.location.protocol?"https://":"http://","sdk.51.la/js-sdk-pro.min.js"),n=e.createElement("script"),r=e.getElementsByTagName("script")[0];n.type="text/javascript",n.setAttribute("charset","UTF-8"),n.async=!0,n.src=c,n.id="LA_COLLECT",i.d=n;var o=function(){s.LA.ids.push(i)};s.LA?s.LA.ids&&o():(s.LA=p,s.LA.ids=[],o()),r.parentNode.insertBefore(n,r)}()}({id:"K9y7iMpaU8NS42Fm",ck:"K9y7iMpaU8NS42Fm"}); 乐鱼在线官网-乐鱼在线 ufc下注官网_ufc竞猜平台【新版本下载】 ufc下注_ufc押注网站 ufc下注官网_ufc竞猜软件【注册登录】 天博APP-天博APP下载-天博APP官方网站 PP下载-天博APP官方网站